Following tail vein injection, mRNA and protein expression of HSV-TK and kallistatin were measured in subcutaneous HepG2 hepatoma tumor xenografts, and in conjunction with the PET data indicated HepG2 tumor targeting [21]. This evidence concerns the gene TKT and neoplasm.